Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 6, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

[Inflammatory myofibroblastic tumor. Case report].

Pablo Garrido Abad1, A Coloma del Peso, M Jiménez Gálvez

  • 1Servicio de Urología, Hospital de La Princesa, Madrid, España. pgabad@hotmail.com

Archivos Espanoles De Urologia
|April 15, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter study of the impact of Urolift® implantation in patients undergoing medical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Actas urologicas espanolas·2025
Same author

Clinical application of the UroLift® prostatic urethral lift in Spain: consensus on the treatment of lower urinary tract symptoms associated with urinary flow obstruction and secondary to benign prostatic hyperplasia (BPH).

Actas urologicas espanolas·2024
Same author

[Evaluation of the PI-RADSv2 classification in a cohort of patients who underwent a prostate fusion biopsy.]

Archivos espanoles de urologia·2020
Same author

Primary arteriocalicial fistula: A dangerously rare cause of hematuria.

Urology case reports·2018
Same author

[Seminal vesicle abscess after acute prostatitis].

Archivos espanoles de urologia·2015
Same author

Testicular rupture after scrotal trauma.

Archivos espanoles de urologia·2014

A rare benign bladder tumor, inflammatory myofibroblastic tumor, was diagnosed in a 30-year-old woman. Transurethral resection (TUR) is the optimal treatment, offering an excellent long-term prognosis for this uncommon condition.

Area of Science:

  • Uropathology
  • Oncology
  • Surgical Pathology

Background:

  • Inflammatory myofibroblastic tumor (IMT) is a rare benign neoplasm of mesenchymal origin.
  • While IMT can occur in various locations, bladder involvement is exceptionally uncommon.
  • Accurate diagnosis is crucial to differentiate IMT from malignant bladder neoplasms.

Observation:

  • A 30-year-old woman presented with recurrent urinary tract infections.
  • Abdominal ultrasound revealed an incidental bladder mass.
  • Histopathological examination post-transurethral resection (TUR) confirmed the diagnosis of IMT.

Findings:

  • The bladder mass was diagnosed as an inflammatory myofibroblastic tumor.
  • This benign tumor, also known as inflammatory pseudotumor or pseudosarcoma, has a mesenchymal origin.

Related Experiment Videos

Last Updated: Jul 6, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

  • The patient's presentation included recurrent urinary tract infections and an incidentally discovered bladder mass.
  • Implications:

    • Transurethral resection (TUR) is the recommended treatment for bladder IMT.
    • Early diagnosis and appropriate management are essential to avoid misdiagnosis as malignancy.
    • Patients with bladder IMT treated with TUR can expect an excellent long-term prognosis.